Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology
| ISRCTN | ISRCTN90482012 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN90482012 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Integrated Research Application System (IRAS) | 319189 |
| Protocol serial number | CPMS 54208 |
| Sponsor | Medical iSight (UK) Limited |
| Funder | Self-funded |
- Submission date
- 14/08/2024
- Registration date
- 03/09/2024
- Last edited
- 16/05/2025
- Recruitment status
- Recruiting
- Overall study status
- Deferred
- Condition category
- Other
Plain English summary of protocol
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Contact information
Principal investigator
Imperial College Healthcare NHS Trust
Charing Cross Hospital
Fulham Palace Road
London
W6 8RF
United Kingdom
 ORCID ID |
0000-0001-5093-9751 |
|---|---|
| k.lobotesis@nhs.net |
Public, Scientific
Medical iSight (UK) Ltd
9th Floor
107 Cheapside
London
EC2V 6DN
United Kingdom
| pjp@medicalisight.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Single-centre interventional trial in patients undergoing interventional neuroradiology procedures |
| Secondary study design | |
| Study type | Participant information sheet |
| Scientific title | Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology |
| Study acronym | MAROG-INR |
| Study objectives | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Ethics approval(s) |
Approved 21/02/2023, London - Dulwich Research Ethics Committee (Skipton House, 80 London Road, London, SE1 6LH, United Kingdom; +44 (0)207 104 8290; dulwich.rec@hra.nhs.uk), ref: 23/LO/0030 |
| Health condition(s) or problem(s) studied | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Intervention | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Intervention type | Other |
| Primary outcome measure(s) |
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Key secondary outcome measure(s) |
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Completion date | 01/07/2026 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 50 |
| Key inclusion criteria | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Key exclusion criteria | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Date of first enrolment | 01/09/2024 |
| Date of final enrolment | 01/04/2026 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
London
W6 8RF
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not expected to be made available |
| IPD sharing plan | The datasets generated and/or analysed during the current study are not expected to be made available because of their high commercial sensitivity and the negligible benefit to the public of publication of results of non-therapeutic clinical trials. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
16/05/2025: The recruitment end date was changed from 21/02/2025 to 01/04/2026.
14/05/2025: The overall end date was changed from 21/02/2025 to 01/07/2026.
08/10/2024: Internal review.
15/08/2024: Study's existence confirmed by the HRA.
